Posted by Michael Wonder on 21 Feb 2017
NICE publishes draft guidance for eluxadoline
21 February 2017 - The Department of Health has asked NICE to produce guidance on using eluxadoline in the NHS in England for patients with irritable bowel syndrome.
Eluxadoline is not recommended within its marketing authorisation for treating irritable bowel syndrome with diarrhoea in adults.
Eluxadoline will be considered at a second appraisal committee meeting on 23 March 2017.
